NASDAQ
No price data available for this timeframe.
Lineage Cell Therapeutics, Inc. (LCTX) has a current ratio of 5.20x as of Tuesday, May 26, 2026. This represents a 83.94% increase compared to its 12-month average of 2.83x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.